Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  HIV Infection

  Free Subscription


Articles published in Nat Med

Retrieve available abstracts of 24 articles:
HTML format



Single Articles


    August 2022
  1. GILBERT PB, Huang Y, deCamp AC, Karuna S, et al
    Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition.
    Nat Med. 2022 Aug 22. pii: 10.1038/s41591-022-01953.
    PubMed     Abstract available


  2. DE BAETSELIER I, Van Dijck C, Kenyon C, Coppens J, et al
    Retrospective detection of asymptomatic monkeypox virus infections among male sexual health clinic attendees in Belgium.
    Nat Med. 2022 Aug 12. pii: 10.1038/s41591-022-02004.
    PubMed     Abstract available


    July 2022
  3. BEKKER LG
    Long-acting agents for HIV treatment and prevention.
    Nat Med. 2022 Jul 22. pii: 10.1038/s41591-022-01917.
    PubMed    


    June 2022
  4. TEGALLY H, Moir M, Everatt J, Giovanetti M, et al
    Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa.
    Nat Med. 2022 Jun 27. pii: 10.1038/s41591-022-01911.
    PubMed     Abstract available


    May 2022
  5. JULG B, Stephenson KE, Wagh K, Tan SC, et al
    Safety and antiviral activity of triple combination broadly neutralizing monoclonal antibody therapy against HIV-1: a phase 1 clinical trial.
    Nat Med. 2022 May 12. pii: 10.1038/s41591-022-01815.
    PubMed     Abstract available


    April 2022
  6. CASAZZA JP, Cale EM, Narpala S, Yamshchikov GV, et al
    Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial.
    Nat Med. 2022 Apr 11. pii: 10.1038/s41591-022-01762.
    PubMed     Abstract available


    March 2022
  7. ARSENAULT C, Gage A, Kim MK, Kapoor NR, et al
    COVID-19 and resilience of healthcare systems in ten countries.
    Nat Med. 2022 Mar 14. pii: 10.1038/s41591-022-01750.
    PubMed     Abstract available


    February 2022
  8. O'LEARY K
    HIV variant causes concern.
    Nat Med. 2022 Feb 14. pii: 10.1038/d41591-022-00034.
    PubMed    


    January 2022
  9. MILLER JS, Davis ZB, Helgeson E, Reilly C, et al
    Safety and virologic impact of the IL-15 superagonist N-803 in people living with HIV: a phase 1 trial.
    Nat Med. 2022 Jan 31. pii: 10.1038/s41591-021-01651.
    PubMed     Abstract available


  10. O'LEARY K
    HIV and skin cancer risk.
    Nat Med. 2022 Jan 6. pii: 10.1038/d41591-022-00001.
    PubMed    


    December 2021

  11. Vaccine development needs a boost.
    Nat Med. 2021 Dec 2. pii: 10.1038/s41591-021-01633.
    PubMed    


  12. DEEKS SG, Archin N, Cannon P, Collins S, et al
    Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021.
    Nat Med. 2021 Dec 1. pii: 10.1038/s41591-021-01590.
    PubMed     Abstract available


  13. MORRIS L
    mRNA vaccines offer hope for HIV.
    Nat Med. 2021;27:2082-2084.
    PubMed    


  14. ZHANG P, Narayanan E, Liu Q, Tsybovsky Y, et al
    A multiclade env-gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques.
    Nat Med. 2021;27:2234-2245.
    PubMed     Abstract available


    November 2021
  15. TANG P, Hasan MR, Chemaitelly H, Yassine HM, et al
    BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar.
    Nat Med. 2021 Nov 2. pii: 10.1038/s41591-021-01583.
    PubMed     Abstract available


    October 2021
  16. BLAZKOVA J, Gao F, Marichannegowda MH, Justement JS, et al
    Distinct mechanisms of long-term virologic control in two HIV-infected individuals after treatment interruption of anti-retroviral therapy.
    Nat Med. 2021 Oct 28. pii: 10.1038/s41591-021-01503.
    PubMed     Abstract available


  17. STEPHENSON KE, Julg B, Tan CS, Zash R, et al
    Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial.
    Nat Med. 2021 Oct 7. pii: 10.1038/s41591-021-01509.
    PubMed     Abstract available


  18. MATTHEWS RP, Patel M, Barrett SE, Haspeslagh L, et al
    Safety and pharmacokinetics of islatravir subdermal implant for HIV-1 pre-exposure prophylaxis: a randomized, placebo-controlled phase 1 trial.
    Nat Med. 2021 Oct 4. pii: 10.1038/s41591-021-01479.
    PubMed     Abstract available


    September 2021
  19. ZHANG F, Karamagi H, Nsenga N, Nanyunja M, et al
    Predictors of COVID-19 epidemics in countries of the World Health Organization African Region.
    Nat Med. 2021 Sep 3. pii: 10.1038/s41591-021-01491.
    PubMed     Abstract available


    July 2021
  20. CHEMAITELLY H, Yassine HM, Benslimane FM, Al Khatib HA, et al
    mRNA-1273 COVID-19 vaccine effectiveness against the B.1.1.7 and B.1.351 variants and severe COVID-19 disease in Qatar.
    Nat Med. 2021 Jul 9. pii: 10.1038/s41591-021-01446.
    PubMed     Abstract available


    June 2021
  21. TURBE V, Herbst C, Mngomezulu T, Meshkinfamfard S, et al
    Deep learning of HIV field-based rapid tests.
    Nat Med. 2021 Jun 17. pii: 10.1038/s41591-021-01384.
    PubMed     Abstract available


  22. DHARAN NJ, Yeh P, Bloch M, Yeung MM, et al
    HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults.
    Nat Med. 2021 Jun 7. pii: 10.1038/s41591-021-01357.
    PubMed     Abstract available


    March 2021
  23. PLANAS D, Bruel T, Grzelak L, Guivel-Benhassine F, et al
    Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.
    Nat Med. 2021 Mar 26. pii: 10.1038/s41591-021-01318.
    PubMed     Abstract available


    November 2020
  24. EDRIDGE AWD, Kaczorowska J, Hoste ACR, Bakker M, et al
    Seasonal coronavirus protective immunity is short-lasting.
    Nat Med. 2020;26:1691-1693.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: